hsa-miR-876-3p

ncRNA information

ncRNA name

hsa-miR-876-3p

Specific or universal ncRNAs

Specific ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

TMED3

Cancer information

Cancer name

Gastric Cancer

Cancer site

Stomach

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

MiR-876-3p enhanced cisplatin sensitivity and restricted stem cell-like features of GC through targeting TMED3.

Tissue resource

gastric cancer tissues and corresponding normal tissues

gastric cancer cell lines MGC-803

gastric cancer cell lines AGS

gastric cancer cell lines BGC-823

gastric cancer cell lines SGC-7901

gastric cancer cell lines MKN-45

gastric cancer cell lines N87

gastric cancer cell lines HGC-27

normal cell lines GES-1

Experiment

PCR,Western blot,Luciferase reporter assay


Institute

the First Affiliated Hospital of Anhui Medical University

American Type Culture Collection

Country

China

USA

Continent

Asia

North American